Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Liang

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
Scientific Reports|March 23, 2017
Erratum: Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone FormationJing Lin, Ming Lu, Wei-Qing Shao, et al.
Scientific Reports|August 4, 2016
Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone FormationJing Lin, Ming Lu, Wei-Qing Shao, et al.
Oral Oncology|June 18, 2017
A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinomaLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 17, 2009
[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR]Yue Zhao, Hu-liang Jia, Hai-jun Zhou, et al.
World Neurosurgery|July 3, 2016
Is There An Optimal Time for Performing Cranioplasties? Results from a Prospective Multinational StudyBoon Leong Quah, Hu Liang Low, Mark H Wilson, et al.
Cancer Management and Research|July 20, 2018
The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinomaYahui Yu, Liangru Ke, Xing Lv, et al.
Journal of Hepatology|March 27, 2010
Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinomaJunfang Ji, Lei Zhao, Anuradha Budhu, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinomaYu-Hua Xue, Xiao-Fei Zhang, Qiong-Zhu Dong, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenomeSonya Parpart, Stephanie Roessler, Fei Dong, et al.
Oncotarget|April 15, 2016
c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPCLiangru Ke, Yanqun Xiang, Xiang Guo, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
Scientific Reports|March 23, 2017
Erratum: Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone FormationJing Lin, Ming Lu, Wei-Qing Shao, et al.
Scientific Reports|August 4, 2016
Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone FormationJing Lin, Ming Lu, Wei-Qing Shao, et al.
Oral Oncology|June 18, 2017
A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinomaLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 17, 2009
[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR]Yue Zhao, Hu-liang Jia, Hai-jun Zhou, et al.
World Neurosurgery|July 3, 2016
Is There An Optimal Time for Performing Cranioplasties? Results from a Prospective Multinational StudyBoon Leong Quah, Hu Liang Low, Mark H Wilson, et al.
Cancer Management and Research|July 20, 2018
The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinomaYahui Yu, Liangru Ke, Xing Lv, et al.
Journal of Hepatology|March 27, 2010
Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinomaJunfang Ji, Lei Zhao, Anuradha Budhu, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinomaYu-Hua Xue, Xiao-Fei Zhang, Qiong-Zhu Dong, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenomeSonya Parpart, Stephanie Roessler, Fei Dong, et al.
Oncotarget|April 15, 2016
c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPCLiangru Ke, Yanqun Xiang, Xiang Guo, et al.
Pageof 22